Wellington Management Group LLP reduced its stake in agilon health, inc. (NYSE:AGL – Free Report) by 0.6% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 52,579,488 shares of the company’s stock after selling 303,107 shares during the period. Wellington Management Group LLP owned 0.13% of agilon health worth $99,901,000 as of its most recent SEC filing.
Other institutional investors also recently made changes to their positions in the company. Oak Thistle LLC bought a new stake in shares of agilon health in the 4th quarter worth approximately $25,000. Ieq Capital LLC acquired a new stake in agilon health in the fourth quarter worth $26,000. Signaturefd LLC lifted its stake in agilon health by 143.0% in the fourth quarter. Signaturefd LLC now owns 14,388 shares of the company’s stock valued at $27,000 after buying an additional 8,467 shares during the last quarter. Point72 Asia Singapore Pte. Ltd. acquired a new position in shares of agilon health during the third quarter valued at $28,000. Finally, Raymond James Financial Inc. bought a new position in shares of agilon health during the fourth quarter worth about $33,000.
Wall Street Analyst Weigh In
AGL has been the topic of several recent research reports. Royal Bank of Canada lifted their price objective on shares of agilon health from $3.00 to $3.50 and gave the company an “outperform” rating in a research report on Wednesday, February 26th. Sanford C. Bernstein lifted their price target on agilon health from $2.50 to $3.15 and gave the company a “market perform” rating in a report on Wednesday, January 15th. Stifel Nicolaus increased their price objective on agilon health from $2.00 to $3.00 and gave the stock a “hold” rating in a report on Wednesday, February 26th. Macquarie assumed coverage on agilon health in a research note on Monday, December 16th. They set a “neutral” rating and a $3.00 target price on the stock. Finally, Needham & Company LLC reiterated a “hold” rating on shares of agilon health in a research report on Friday, March 21st. Two investment analysts have rated the stock with a sell rating, thirteen have issued a hold rating and two have given a buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus price target of $3.95.
agilon health Stock Down 1.8 %
NYSE AGL opened at $4.00 on Friday. The company has a market capitalization of $1.65 billion, a P/E ratio of -4.25 and a beta of 0.67. agilon health, inc. has a 12 month low of $1.50 and a 12 month high of $7.73. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.29 and a quick ratio of 1.29. The company’s 50 day simple moving average is $3.73 and its 200 day simple moving average is $3.00.
agilon health Company Profile
agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.
Further Reading
- Five stocks we like better than agilon health
- How to Calculate Stock Profit
- Shares of RH Down Nearly 40%: Where Investors Can Turn To Now
- Retail Stocks Investing, Explained
- Tariffs, Spin-Out, and R2 Updates Are Positive Signs for Rivian
- Insider Buying Explained: What Investors Need to Know
- Cathie Wood Loads Up on Baidu—Is It the Right Time to Buy?
Want to see what other hedge funds are holding AGL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for agilon health, inc. (NYSE:AGL – Free Report).
Receive News & Ratings for agilon health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for agilon health and related companies with MarketBeat.com's FREE daily email newsletter.